Vimarsana
Biggest News Aggregation in the World

Page 9 - Poster Presentations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Presentations Today - Breaking & Trending Today

Ardelyx to Present Poster Presentations on IBSRELA® (tenapanor) for Adult Patients with IBS-C at the American College of Gastroenterology 2022 Annual Scientific Meeting - Vimarsana News

Ardelyx to Present Poster Presentations on IBSRELA® (tenapanor) for Adult Patients with IBS-C at the American College of Gastroenterology 2022 Annual Scientific Meeting

Published: October 24, 2022

/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...

Source: prnewswire.com
Related Topics:
United StatesNorth CarolinaSusanl LucakLaura WilliamsSusan LucakFosun PharmaArdelyx IncColumbia University Medical CenterAmerican College Of Gastroenterology Annual Scientific MeetingGastroenterology Annual Scientific MeetingPoster PresentationsPost Hoc AnalysisMulti Item Abdominal Score FromWeek PhaseChronic Idiopathic ConstipationIrritable Bowel SyndromeProduct TheaterWeill Cornell MedicineLenox Hill Hospital New YorkSerious DehydrationPrescribing InformationBoxed WarningKyowa KirinKnight Therapeutics
Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022 - Vimarsana News

Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022

Published: October 20, 2022

/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...

Source: prnewswire.com
Related Topics:
United StatesOrange County Convention CenterFosun PharmaPrnewswire Ardelyx IncAmerican Society Of NephrologyKyowa Kirin Co LtdArdelyx IncAmerican SocietyKidney WeekKyowa KirinPoster PresentationsPredictive ValueEarly ResponsePatients Receiving MaintenanceExhibit HallSerum PhosphorusWith TenapanorChronic Kidney DiseaseDialysis With SevereReduces Interdialytic Weight GainPost Hoc AnalysisKirin Poster PresentationsJapanese Hemodialysis PatientsRandomized PhaseTenapanor Added
Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022 - Vimarsana News

Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022

Published: October 20, 2022

WALTHAM, Mass., Oct. 20, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...

Source: businessinsider.com
Related Topics:
United StatesOrange County Convention CenterFosun PharmaPrnewswire Ardelyx IncAmerican Society Of NephrologyKyowa Kirin Co LtdArdelyx IncAmerican SocietyKidney WeekKyowa KirinPoster PresentationsPredictive ValueEarly ResponsePatients Receiving Maintenance DialysisExhibit HallWest BuildingSerum PhosphorusWith TenapanorChronic Kidney DiseaseDialysis With Severe HyperphosphatemiaReduces Interdialytic Weight GainPost Hoc AnalysisKirin Poster PresentationsJapanese Hemodialysis PatientsRandomized Phase
Precision BioSciences, Inc.: Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress - Vimarsana News

Precision BioSciences, Inc.: Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress

Published: October 11, 2022

Oral and Poster Presentations to Highlight Preclinical Research for ARCUS Gene Editing Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo

Source: finanznachrichten.de
Related Topics:
Cromdale HallWendy ShoopMei BurrisDerek JantzMaurissa MessierPrecision Biosciences IncEuropean Society Of Gene Cell TherapyEdinburgh International Conference CentreCorporate CommunicationsCongress OnPoster Presentations To Highlight Preclinical ResearchPoster PresentationsHighlight Preclinical ResearchEuropean SocietyGene Cell TherapyEdinburgh International ConferencePoster NumberChief Scientific Officer StrategyPrecision BiosciencesInvestor Relations
Breaking Data on the Efficacy and Cost-Effectiveness of an Exclusive Human Milk Diet for Premature Infants To Be Presented at the American Academy of Pediatrics 2022 National Conference - Vimarsana News

Breaking Data on the Efficacy and Cost-Effectiveness of an Exclusive Human Milk Diet for Premature Infants To Be Presented at the American Academy of Pediatrics 2022 National Conference

Published: October 7, 2022

/PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature...

Source: prnewswire.com
Related Topics:
United StatesAnaheim Convention CenterLoren KosmontAnaheim MarriottProlacta BiosciencePrnewswire Prolacta BiosciencePediatr Gastroenterol NutrJenny FoxMelindaj ElliottSarahm ReyesAmerican Academy Of PediatricsEuropean Society Of Paediatric GastroenterologyPediatrics National ConferenceDrug AdministrationNutrition Committee OnNational ConferenceAmerican Academy Of Pediatrics National ConferenceMarquis Ballroom CenterAmerican AcademyExclusive Human Milk DietPoster PresentationsPreterm InfantsReal World ExperienceVirginia Commonwealth UniversityExclusive Human Milk Diet With Morbidity